- Home
- / ESSA Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ESSA Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$6.2
2024-09-26
Market Capitalization
$275.5 M
2024-09-26
CreditSafe Score
?
Score changed on Oct 04, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| General and administrative expense | 5.9M | 5.5M | 11.4M | 12.9M | 12.5M | 10.8M |
| Operating expense total | 10.8M | 12.2M | 23.5M | 37.1M | 37.0M | 32.1M |
| Investment income | (374.0) | |||||
| Interest income | 1.7M | 5.6M | ||||
| Pre tax profit | (11.6M) | (10.4M) | (23.7M) | (36.8M) | (35.2M) | (26.6M) |
| Income tax expense | 27.0K | 37.9K | (288.6K) | (34.3K) | (111.8K) | 1.6K |
| Net Income | (11.6M) | (10.4M) | (23.4M) | (36.8M) | (35.1M) | (26.6M) |
| EPS | (0.8) | (0.6) |